Türk Kanser Derneği
Türk Kanser Derneği is a Turkish non-profit founded in 1964 that provides free accommodation, psychological, nutritional, screening, legal, and digital patient-tracking services to cancer patients in Turkey, funded by individual donations and corporate sponsorships including Roche, Pfizer, and major Turkish conglomerates.
- Company typePrivate
- Founded1964
- HeadquartersIstanbul
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Türk Kanser Derneği does
Türk Kanser Derneği (Turkish Cancer Association) is a Turkish non-profit association (dernek) founded in 1964 and headquartered in Istanbul that delivers a comprehensive portfolio of free support services to cancer patients and their families. Its core service platform centers on the Mucizevi Konaklama ve Yaşam Merkezi, a free accommodation and living center for patients traveling from outside Istanbul for treatment, complemented by psychological support, nutrition counseling, treatment follow-up and second opinion coordination, genetic testing, legal counseling, early diagnosis screening, financial grants, and in-kind support packages. Since 2018 the organization has documented delivery of 1,892 accommodation supports, 724 financial grants, 1,470 psychological support sessions, 761 nutrition consultations, 1,526 treatment follow-up/second opinion services, and 5,121 cancer screenings.
Its digital offering, the onKOlay patient tracking and management application, was developed in collaboration with Roche (primary sponsor) and Albert Health (technology partner) and provides treatment follow-up, symptom diaries, medication reminders, lab result tracking, measurement history, and voice-assisted mood monitoring. The app is publicly available on the Google Play Store. The organization also operates awareness projects including the skin cancer 'Gölge Oyunu' shadow puppetry initiative sponsored by Maruderm, the 'Sağlıklı Çocuk Sağlıklı Türkiye' school health education program with Turkey's Ministry of National Education, the pediatric 'Sevimli Serum Kutuları' program, the Hospis hospice program, and earthquake support programs launched after the February 2023 Kahramanmaraş earthquakes.
The organization operates entirely through donations and is funded via individual contributions (website, SMS short-code 3853 with keyword DESTEK, and bank transfers in TRY/USD/EUR), corporate partnerships and sponsorships with pharmaceutical companies (Roche, Pfizer, MSD, Bristol Myers Squibb, Janssen), private hospital groups (Acıbadem, Memorial, Medical Park, Florence Nightingale), Turkish conglomerates (Sabancı Holding, Eczacıbaşı Holding, Zorlu Holding), and consumer brands, in-kind product donations, commemorative Special Day Certificates (Özel Gün Sertifikaları), and annual membership fees processed through fonzip.com. Marketing relies on a multi-channel approach combining the turkkanserdernegi.org website, social media, celebrity ambassador campaigns, earned media coverage across major Turkish outlets, awareness marathons, and corporate workshop programs. The Chairman of the Board is Burak Duruman.
Türk Kanser Derneği firmographics
Firmographics- Name
- Türk Kanser Derneği
- Legal name
- Türk Kanser Derneği
- Website
- https://turkkanserdernegi.org
- Company type
- Private
- Founded year
- 1964
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Türk Kanser Derneği is a Turkish non-profit founded in 1964 that provides free accommodation, psychological, nutritional, screening, legal, and digital patient-tracking services to cancer patients in Turkey, funded by individual donations and corporate sponsorships including Roche, Pfizer, and major Turkish conglomerates.
- Ownership category
- akta.pro rank
Türk Kanser Derneği industry classification
Industry- Product category
- Cancer Patient Support Services
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Palliative Care Clinics & Outpatient Programs (HLADAHAF)
- akta.pro secondary industries
- ENT (Otolaryngology) Telemedicine Platforms (HLALAGAM), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
Keywords
Where Türk Kanser Derneği is headquartered
LocationHeadquarters
- HQ city
- Istanbul
Offices1 record
Markets served
Türk Kanser Derneği business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Individual Donations: Individual donors contribute through the organization's website using preset amounts (500₺, 1000₺, 2000₺, 2500₺) or custom donation values. SMS donations are also accepted via 3853 with keyword DESTEK. Bank transfers to Akbank, İş Bankası, QNB Finansbank, and Vakıfbank accounts in Turkish Lira, USD, and Euro.
- Corporate Partnerships and Sponsorships: Corporate partners provide financial sponsorships for specific projects, event sponsorships, room sponsorships at the Mucizevi accommodation center, and product/service donations. Partners include pharmaceutical companies (Roche, Pfizer, MSD, Bristol Myers Squibb, Janssen), healthcare institutions, and consumer brands.
- In-Kind Donations: Donations of goods including food, clothing, toys, books, tablets, computers, medical supplies, and hygiene products for cancer patients and the Mucizevi accommodation center. Basic food donations for the center's meal program are also accepted.
- Special Day Certificates: Organizations can purchase special day certificates for employees, with proceeds supporting cancer patients. These certificates are offered as an alternative to traditional gifts for special occasions.
- Membership Fees: Annual membership fees collected from association members through the fonzip.com online payment platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Free Services for Cancer Patients |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Türk Kanser Derneği product offering
Product offeringCore offering
Türk Kanser Derneği is a non-profit association providing free, comprehensive support services to cancer patients in Turkey, including lodging at the Mucizevi Accommodation Center for out-of-town patients, psychological counseling, nutritional consulting, genetic testing, second opinion coordination, free cancer screenings, legal counseling on health rights, and in-kind aid. The association also operates the onKOlay digital patient tracking application developed with Roche and Albert Health.
Product overview
Türk Kanser Derneği operates as a cancer-focused nonprofit organization offering a portfolio of support services rather than a unified software product. The primary digital offering is onKOlay, a digital patient tracking and management application developed in partnership with Albert Health and sponsored by Roche. The organization's service ecosystem centers on Mucizevi Konaklama ve Yaşam Merkezi (accommodation center) as a hub for in-person patient support, complemented by various screening, psychological, nutritional, legal counseling, and genetic testing services. Additional projects include awareness campaigns (Gölge Oyunu, Sağlıklı Çocuk Sağlıklı Türkiye), patient support initiatives (Sevimli Serum Kutuları, Hospis), and emergency response programs (Deprem Destek Programları). Donation products include Özel Gün Sertifikaları for commemorative giving.
Differentiator
Problem solved
Functional benefit
Brands
- Mucizevi Konaklama ve Yaşam Merkezi: Free accommodation and living center for cancer patients traveling from outside Istanbul to receive treatment, providing lodging, meals, and psychosocial support services.
- onKOlay
Quantifiable outcome
- 1892 patients provided accommodation support since 2018
- +3 more outcomes
Companies that use Türk Kanser Derneği
Customer profileSegments4 records
Ideal customer profiles3 records
Türk Kanser Derneği technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Türk Kanser Derneği partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core, minor and moderate.
- RochecorePharmaceutical company Roche serves as the primary sponsor for the onKOlay digital patient tracking application. Roche's sponsorship enabled the development and deployment of this innovative telehealth platform for cancer patients.
- Albert HealthcoreTechnology partner that collaborated with Türk Kanser Derneği to develop the onKOlay digital patient tracking application, providing the technical platform and voice assistant capabilities.
- SportiveminorSportive partnered with Türk Kanser Derneği for National Cancer Week (1-7 April) awareness events, including a awareness walk with ultra-marathon runner Alper Dalkılıç in Suadiye and an open-air program in Caddebostan featuring expert talks on nutrition, early diagnosis, and psychological resilience.
- Eker (Dairy Company)minorEker provided product sponsorship for awareness events, supplying healthy breakfast products for participants.
- Fellas FoodsminorFellas Foods provided product sponsorship for National Cancer Week awareness event, supporting healthy breakfast provisions.
- Maruderm Laboratoire DermatologiquecoreMaruderm served as main sponsor (ana sponsor) for the 'Gölge Oyunu Oynamaya Var mısın?' (Shadow Play Skin Cancer Awareness) project and event. The partnership included product donations for event participants and support for skin cancer awareness activities at Kemerburgaz City Forest.
- Acıbadem Healthcare GroupmoderateMajor private healthcare institution listed as a partner, providing medical services and referrals for cancer patients supported by the association.
- Memorial Health GroupmoderateMajor private hospital group listed as a partner, offering medical services and healthcare institution collaborations for cancer patient support.
- Medical Park Hospitals GroupmoderateLarge hospital network listed as a healthcare partner, providing treatment services and institutional support for cancer patients.
- Florence Nightingale HospitalsmoderateRenowned private hospital group listed as a partner healthcare institution for cancer treatment and patient referrals.
- Psychooncology Association (Psikoonkoloji Derneği)moderateProfessional association whose president Elif Özlük Yeşildere participated in awareness events and provides expert psychological support knowledge for cancer patients.
- AHBAPmoderateGrassroots solidarity organization listed as an institutional supporter, particularly active in disaster relief efforts including support for earthquake-affected cancer patients.
- Disaster Platform (Afet Platformu)moderateCoalition of disaster relief organizations including Türk Kanser Derneği, coordinating support for disaster-affected populations including cancer patients following the 2023 earthquakes.
- GetirminorTurkish quick commerce company listed among institutional supporters, providing delivery/logistics support for the association.
- IKEA TurkeyminorFurniture and home goods retailer listed among supporters, potentially providing furnishing support for the Mucizevi accommodation center.
- YataşminorBed and mattress manufacturer listed among supporters, likely providing sleeping products for the Mucizevi accommodation center.
- VestelminorTurkish electronics manufacturer listed among institutional supporters.
- Demiroğlu Bilim UniversityminorPrivate university listed among healthcare institution supporters, potentially providing academic/research collaboration.
- Ministry of National EducationcoreGovernment ministry collaborating on the 'Healthy Child Healthy Turkey' project, supporting nationwide expansion of health education programs in schools.
- Istanbul PlakminorRecord label that released the 'Jazz'ın Kanatları' (Jazz's Wings) charity album with all proceeds going to Türk Kanser Derneği.
- D&RminorMajor Turkish book and media retailer distributing the charity album 'Jazz'ın Kanatları' with proceeds supporting the association.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
Türk Kanser Derneği competitors and assessment
Company assessmentEmerging players
- Livestrong Foundation: US-based cancer survivor support organization providing navigation, financial assistance, and emotional support services. Comparable in mission focus on improving cancer patients' quality of life through non-clinical support.
Direct peers
- Macmillan Cancer Support: UK-based cancer support charity providing financial assistance, accommodation, psychological support, and information services. Closest international functional peer with a similar holistic cancer patient support model.
- Kanserli Çocuklara Umut Vakfı (KAÇUV): Turkish foundation focused on children with cancer and their families, providing accommodation, psychosocial support, and educational programs. Directly comparable in mission, services, and Turkish operating context.
- Kanser Savaşçıları Derneği: Turkish association of cancer survivors/patients providing peer support, awareness, and patient advocacy. Comparable as a Turkey-based cancer patient support NGO operating alongside TKD.
- LÖSEV (Lösemili Çocuklar Sağlık ve Eğitim Vakfı): Turkey's leading pediatric leukemia and cancer foundation, also providing free accommodation, treatment support, and psychosocial services. Closest direct peer as another major Turkish cancer NGO with a comparable multi-service support model.
- American Cancer Society: Largest US cancer-focused NGO providing patient support, accommodation (Hope Lodges), screening programs, and research funding. Direct functional peer in offering multi-disciplinary cancer support services to patients at no charge.
Broad incumbents
- Susan G. Komen: Major international breast cancer non-profit combining awareness, patient support, and research funding. Comparable as a long-established cancer NGO with strong corporate partnerships and patient services.
- Cancer Research UK: UK cancer charity with a broader research and awareness mandate. Comparable as an established cancer-focused non-profit with national brand recognition and corporate partnership ecosystem.
- Acıbadem Healthcare Group Foundation: Major Turkish private healthcare group and listed TKD partner providing oncology treatment infrastructure. Comparable as a healthcare-services organization in the Turkish cancer care ecosystem, though focused on clinical delivery rather than non-clinical support.
Others
- Roche (Pharma Sponsor): Primary sponsor of TKD's onKOlay app and a major corporate supporter. Listed as an ecosystem/funder rather than competitor, but Roche's broader patient support programs and oncology therapies make it an adjacent player in the cancer care ecosystem.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Türk Kanser Derneği social profiles
Digital presenceTürk Kanser Derneği financial estimates
Financial estimateRevenue estimate
Valuation estimate
Türk Kanser Derneği leadership team
Management profileNumber of profiles
Profiles4 records
Türk Kanser Derneği funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Türk Kanser Derneği M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Türk Kanser Derneği
What does Türk Kanser Derneği do?
Türk Kanser Derneği is a non-profit association providing free, comprehensive support services to cancer patients in Turkey, including lodging at the Mucizevi Accommodation Center for out-of-town patients, psychological counseling, nutritional consulting, genetic testing, second opinion coordination, free cancer screenings, legal counseling on health rights, and in-kind aid. The association also operates the onKOlay digital patient tracking application developed with Roche and Albert Health.
Is Türk Kanser Derneği a public or private company?
Türk Kanser Derneği is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Türk Kanser Derneği founded?
Türk Kanser Derneği was founded in 1964. It employs 1 to 10 people.
Where is Türk Kanser Derneği based?
Türk Kanser Derneği is headquartered in Istanbul.
How does Türk Kanser Derneği make money?
Five revenue lines are on record. Individual Donations are the primary driver. The others are corporate Partnerships and Sponsorships, in-Kind Donations, special Day Certificates and membership Fees.
Who are Türk Kanser Derneği's main competitors?
Livestrong Foundation is listed as an emerging player. Direct peers are Macmillan Cancer Support, Kanserli Çocuklara Umut Vakfı (KAÇUV), Kanser Savaşçıları Derneği, LÖSEV (Lösemili Çocuklar Sağlık ve Eğitim Vakfı) and American Cancer Society. Broad incumbents are Susan G. Komen, Cancer Research UK and Acıbadem Healthcare Group Foundation. Roche (Pharma Sponsor) is listed as an others.
Does Türk Kanser Derneği have an API?
No public API is recorded for Türk Kanser Derneği.
What industry is Türk Kanser Derneği in?
Türk Kanser Derneği's product category is Cancer Patient Support Services. Its primary akta.pro industry code is HLADAHAF, Palliative Care Clinics & Outpatient Programs, with a secondary code of HLALAGAM, ENT (Otolaryngology) Telemedicine Platforms. Its NAICS code is 62 and its SIC code is 8000.